India Approves Further Trials For MRNA Covid-19 Shot

Sinhaajay397@gmail.c11 Oct, 2021News

India has approved further clinical trials for its first homegrown mRNA-based COVID-19 vaccine developed by Gennova Biopharmaceuticals Ltd., the government said on Tuesday, after the shot was found to be safe and effective in an early-stage study. Gennova is among a few pharmaceutical firms worldwide, including Moderna Inc and Pfizer Inc, to use mRNA technology in its coronavirus shot. These vaccines do not use a live virus to generate an immune response but prompt the human body to make a protein that triggers one.